ASCCP guidelines and breast imaging on the heels of COVID-19
We hear from Christine Isaacs, MD about the new ASCCP guidelines and what they mean for ob/gyns.
The new ASCCP guidelines expand recommendations for cervical cancer screening to include screening every 5 years with primary high-risk human papillomavirus (hrHPV) testing. If you missed Isaacs' presentation at the 2021 ACOG ACSM, “While You Were Slee(PPE)ing: Women’s Health Updates Beyond the Pandemic’s Priorities,” read a summary here.
The guidelines were released in 2020 and, in 2021, were endorsed by the American College of Obstetricians and Gynecologists (ACOG) and the Society of Gynecologic Oncology (SGO).
Rebecca B. Perkins, MD, MSC, also presented the guidelines at ACOG’s Annual Clinical and Scientific Meeting earlier this year.
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
